Elizabeth Glynn Nilson, MD - Medicare Internal Medicine in Burlington, MA

Elizabeth Glynn Nilson, MD is a medicare enrolled "Internal Medicine" physician in Burlington, Massachusetts. She went to University Of Massachusetts Medical School and graduated in 1995 and has 29 years of diverse experience with area of expertise as Internal Medicine. She is a member of the group practice Lahey Clinic Inc and her current practice location is 67 S Bedford St Ste 202e, Burlington, Massachusetts. You can reach out to her office (for appointments etc.) via phone at (781) 744-7000.

Elizabeth Glynn Nilson is licensed to practice in Massachusetts (license number 238648) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1639112022.

Contact Information

Elizabeth Glynn Nilson, MD
67 S Bedford St Ste 202e,
Burlington, MA 01803-5141
(781) 744-7000
(781) 744-7516



Physician's Profile

Full NameElizabeth Glynn Nilson
GenderFemale
SpecialityInternal Medicine
Experience29 Years
Location67 S Bedford St Ste 202e, Burlington, Massachusetts
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Elizabeth Glynn Nilson attended and graduated from University Of Massachusetts Medical School in 1995
  NPI Data:
  • NPI Number: 1639112022
  • Provider Enumeration Date: 06/14/2006
  • Last Update Date: 04/14/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 3779588504
  • Enrollment ID: I20090423000642

Medical Identifiers

Medical identifiers for Elizabeth Glynn Nilson such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1639112022NPI-NPPES
110082094AMedicaidMA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2083P0901XPreventive Medicine - Public Health & General Preventive Medicine 238648 (Massachusetts)Secondary
207R00000XInternal Medicine 238648 (Massachusetts)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Lahey Health At HomeBeverly, MAHome health agency
Elara CaringByfield, MAHome health agency
Lahey Hospital & Medical Center, BurlingtonBurlington, MAHospital
Winchester HospitalWinchester, MAHospital
Beth Israel Deaconess Medical CenterBoston, MAHospital
Northeast Hospital CorporationBeverly, MAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Lahey Clinic Inc22643365281211

News Archive

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) products for the treatment of HIV/AIDS.

Researchers explore how the brain changes over the course of Alzheimer's disease

What changes in the brain are caused by Alzheimer's disease? How do these changes differ from those observed in the normal aging process? Researchers from the CNRS, the école pratique des hautes études and the University of Valencia explored these questions by analyzing over 4,000 MRI scans of healthy and diseased brains using the "volBrain" platform.

NanoViricides reports improved efficacy with optimized FluCide nanoviricide drug candidates for influenza

NanoViricides, Inc. reported dramatically improved antiviral efficacy with its optimized FluCide™ drug candidates in its most recent animal study.

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Elizabeth Glynn Nilson allows following entities to bill medicare on her behalf.
Entity NameLahey Clinic Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1538194980
PECOS PAC ID: 2264336528
Enrollment ID: O20031120000097

News Archive

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) products for the treatment of HIV/AIDS.

Researchers explore how the brain changes over the course of Alzheimer's disease

What changes in the brain are caused by Alzheimer's disease? How do these changes differ from those observed in the normal aging process? Researchers from the CNRS, the école pratique des hautes études and the University of Valencia explored these questions by analyzing over 4,000 MRI scans of healthy and diseased brains using the "volBrain" platform.

NanoViricides reports improved efficacy with optimized FluCide nanoviricide drug candidates for influenza

NanoViricides, Inc. reported dramatically improved antiviral efficacy with its optimized FluCide™ drug candidates in its most recent animal study.

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.

Read more Medical News

› Verified 6 days ago

Entity NameLahey Clinic Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1063447316
PECOS PAC ID: 2264336528
Enrollment ID: O20040629001269

News Archive

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) products for the treatment of HIV/AIDS.

Researchers explore how the brain changes over the course of Alzheimer's disease

What changes in the brain are caused by Alzheimer's disease? How do these changes differ from those observed in the normal aging process? Researchers from the CNRS, the école pratique des hautes études and the University of Valencia explored these questions by analyzing over 4,000 MRI scans of healthy and diseased brains using the "volBrain" platform.

NanoViricides reports improved efficacy with optimized FluCide nanoviricide drug candidates for influenza

NanoViricides, Inc. reported dramatically improved antiviral efficacy with its optimized FluCide™ drug candidates in its most recent animal study.

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Elizabeth Glynn Nilson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Elizabeth Glynn Nilson, MD
41 Mall Rd, Lahey Clinic,
Burlington, MA 01805-0001

Ph: (781) 744-7000
Elizabeth Glynn Nilson, MD
67 S Bedford St Ste 202e,
Burlington, MA 01803-5141

Ph: (781) 744-7000

News Archive

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) products for the treatment of HIV/AIDS.

Researchers explore how the brain changes over the course of Alzheimer's disease

What changes in the brain are caused by Alzheimer's disease? How do these changes differ from those observed in the normal aging process? Researchers from the CNRS, the école pratique des hautes études and the University of Valencia explored these questions by analyzing over 4,000 MRI scans of healthy and diseased brains using the "volBrain" platform.

NanoViricides reports improved efficacy with optimized FluCide nanoviricide drug candidates for influenza

NanoViricides, Inc. reported dramatically improved antiviral efficacy with its optimized FluCide™ drug candidates in its most recent animal study.

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.

Read more News

› Verified 6 days ago


Internal Medicine Doctors in Burlington, MA

Joseph Dubin,
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 41 Mall Rd., Lahey Clinic, Burlington, MA 01805
Phone: 781-744-7000    Fax: 781-744-5378
Gerard Daly, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 41 Mall Rd, Burlington, MA 01805
Phone: 781-744-5700    Fax: 781-744-5358
Sahoor Khan,
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 41 Mall Rd, Burlington, MA 01805
Phone: 781-744-8000    
Kristen M Robson, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: Lahey Clinic, 41 Mall Road, Burlington, MA 01805
Phone: 781-744-8699    Fax: 781-744-5276
Eric Scott Kerns, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 41 Mall Road, Lahey Hospital & Medical Center, Burlington, MA 01805
Phone: 781-744-8430    Fax: 781-744-5397
Neethi Rebekah Dasu, DO
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 41 Mall Rd, Burlington, MA 01805
Phone: 781-744-8000    
Frederick W Heiss, MD
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: Lahey Clinic, 41 Mall Road, Burlington, MA 01805
Phone: 781-744-5100    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.